...
首页> 外文期刊>Gene therapy >In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression
【24h】

In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression

机译:利用基因靶向片段恢复SMN蛋白表达的脊髓肌萎缩成纤维细胞系体外基因操作

获取原文
获取原文并翻译 | 示例
           

摘要

The reduced level of survival motor neuron (SMN) protein, caused by homozygous deletions in the SMN gene, led to a common neurodegenerative disorder known as spinal muscular atrophy (SMA). In spite of extensive efforts to find a cure for SMA, there is currently no effective treatment available for this devastating disease. In this study, restoration of SMN expression through 'gene-targeting' method in SMA fibroblast cells was attempted. We designed a 2697-bp gene-targeting cassette; it consisted of an SMN1 open reading frame expressing 38 kD SMN protein and the upstream and downstream regions of exon 1 of SMN1 gene at the ends as the homology arms. SMA fibroblast cells were transfected by gene-targeting cassette using Lipofectamine LTX-PLUS reagent. Occurrence of homologous recombination in selected cells was investigated by PCR analysis. Increased expression of SMN protein was shown by real-time PCR and western blotting analysis. The immunofluorescence analysis results demonstrated that the number of SMN nuclear structures, Gems, was the same as or greater than the number of Gems found in normal fibroblasts. The results of this study indicate that gene-targeting methods do, in fact, present as an alternative for restoration of SMN expression in SMA patients-derived cells in vitro.
机译:由SMN基因的纯合缺失导致的存活运动神经元(SMN)蛋白水平降低,导致了一种常见的神经退行性疾病,即脊髓性肌萎缩症(SMA)。尽管为寻找SMA的治愈方法付出了巨大的努力,但目前尚无针对这种破坏性疾病的有效治疗方法。在这项研究中,试图通过“基因靶向”方法在SMA成纤维细胞中恢复SMN表达。我们设计了一个2697 bp的基因靶向盒。它由一个表达38 kD SMN蛋白的SMN1开放阅读框和SMN1基因外显子1的上游和下游区域作为同源臂组成。使用Lipofectamine LTX-PLUS试剂通过基因靶向盒转染SMA成纤维细胞。通过PCR分析研究在所选细胞中同源重组的发生。通过实时PCR和western印迹分析显示SMN蛋白表达增加。免疫荧光分析结果表明,SMN核结构Gems的数量等于或大于正常成纤维细胞中发现的Gems的数量。这项研究的结果表明,事实上,基因靶向方法确实可以作为在SMA患者衍生细胞中恢复SMN表达的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号